Sencure
Founded 2021 · 26 employees on LinkedIn · 2 known investors
Sencure designs integrated biosensor chips for wearable health monitoring and medical devices, offering signal processing and electrophysiology expertise. The company serves device manufacturers building health monitoring and wellness applications.
Investors · 2
Funding
SEC filings, press & company announcements$5.4M disclosed across 1 round · 2023
- $5.4MraisedJul 2023 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlapNextCure4 shared keywordsNextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.
Nexcure3 shared keywordsNexCure partners with health systems to build and operate outpatient treatment centers focused on delivering advanced cancer therapies such as CAR-T and T-cell engagers. Its platform combines AI-powered patient selection, remote monitoring, and standardized clinical protocols to bring these treatments to patients in outpatient settings across the country.
Companies competing with Sencure for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Sencure do?
- Sencure designs integrated biosensor chips for wearable health monitoring and medical devices, offering signal processing and electrophysiology expertise. The company serves device manufacturers building health monitoring and wellness applications.
- Who are Sencure's investors?
- Sencure's investors include Cottonwood Technology Fund, NV NOM.
- How much funding has Sencure raised?
- Sencure has disclosed $5.4M raised across 1 round.